News archive search

Search the Newsreel

Search stored headlines and summaries, then narrow the results by company, country, sector, industry, source or date.

Showing
145–180
Matches
3511
Sources here
23
Companies here
28
Search results Stored financial headlines

Active search

3511 matching headlines

Ticker or company: ARIMain company stories
Clear

Search results

Matching headlines

External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.

Jim Cramer Said Arista Networks, Inc. (NYSE:ANET) and Snowflake Inc. (NYSE:SNOW) Were Worth It

Networking equipment and software provider Arista Networks, Inc. (NYSE:ANET) is one of Cramer's favorite stocks. In fact, as far back as February 2025, the CNBC TV host remarked that going against Arista Networks, Inc. (NYSE:ANET) and its CEO meant an "invitation to your funeral." …

ANET main company A1NE34 main company ANET main company
Sharemaestro market context Trend signal active 52 weeks +36.9% ANET stored weekly price path from 22 Aug 2025 to 14 Aug 2026

ETFs Investing in Clarivate PLC Stocks

This article lists various Exchange Traded Funds (ETFs) that hold Clarivate PLC (16A) stocks, providing investors with options to invest in the company indirectly. Each ETF entry includes details such as market value, weight of Clarivate PLC in the fund, issuer, management style, focus, …

CLVT main company
Sharemaestro market context Price below Trend Line 52 weeks -57.1% · Next-week setup negative 41.5% CLVT stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Dimensional Fund Advisors LP Has $1.91 Million Stock Position in Aclaris Therapeutics, Inc. $ACRS

Dimensional Fund Advisors LP significantly increased its stake in Aclaris Therapeutics, Inc. by 88.8% in the first quarter, now holding 511,461 shares valued at approximately $1.91 million. This move is part of a broader trend of institutional investment, with such entities owning 98.34% of …

ACRS main company
Sharemaestro market context Trend signal active 52 weeks +221.1% ACRS stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Martin Marietta Materials raises dividend to $0.84 per share

* Martin Marietta Materials (MLM [https://seekingalpha.com/symbol/MLM]) declares $0.84/share quarterly dividend [https://seekingalpha.com/pr/20619149-martin-marietta-increases-quarterly-cash-dividend], 1.2% increase from prior dividend of $0.83. * Forward yield [https://seekingalpha.com/symbol/MLM/dividends/yield?source=news_bullet] 0.62% * Payable Sept. 30; for shareholders of record Sept. 1; ex-div Sept. 1. * See MLM Dividend Scorecard, Yield Chart, & …

M1LM34 main company MLM main company
Sharemaestro market context Price below Trend Line 52 weeks -10.0% · Next-week setup negative 8.4% M1LM34 stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Form 8K Martin Marietta Materials Inc For: 14 August By Investing.com

This article reports on the filing of a Form 8K by Martin Marietta Materials Inc. on August 14th. The brief announcement provides no specific details from the filing but notes its availability through Investing.com. It indicates that the company's stock symbol is MLM.

MLM main company
Sharemaestro market context Price below Trend Line 52 weeks -9.4% MLM stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Martin Marietta Materials (MLM) Stock May Trade Below Fair Value Today

Never miss an important update on your stock portfolio and cut through the noise. Over 7 million investors trust Simply Wall St to stay informed where it matters for FREE. Martin Marietta Materials stock sits at an interesting crossroads, with the intrinsic value estimate …

M1LM34 main company MLM main company
Sharemaestro market context Price below Trend Line 52 weeks -10.0% · Next-week setup negative 8.4% M1LM34 stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Arista Networks Stock Is Priced For Its Peak Margin

Arista Networks (ANET) stock is trading at a 52-week high, with a price-to-sales multiple higher than any point in its ten-year history. The article argues that the stock's high valuation is predicated on peak profitability, even as its gross margin has declined year-over-year. Investors …

ANET main company
Sharemaestro market context Trend signal active 52 weeks +49.2% · Next-week setup positive 58.8% ANET stored weekly price path from 22 Aug 2025 to 14 Aug 2026

RBC Bearings (RBC) Stock Price Slips As Premium Margins Meet Valuation Strain

RBC Bearings' stock price slipped despite strong Q1 2027 earnings, with revenue up 19.2% and adjusted EPS rising 36.6%. The market appears cautious due to the company's premium valuation (P/E of 60.5x) and concerns about the sustainability of its high margins, some of which …

RBC main company
Sharemaestro market context Trend signal ended 52 weeks +39.6% · Next-week setup positive 72.2% RBC stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Caribou Biosciences (NASDAQ:CRBU) Releases Earnings Results, Beats Expectations By $0.08 EPS

Caribou Biosciences (NASDAQ:CRBU) reported a quarterly loss of $0.24 per share, surpassing analyst expectations by $0.08, though revenue of $1.50 million fell short of estimates. Following the announcement, shares declined by 5.3% to $1.61. Despite substantial losses and a negative net margin, institutional investors …

CRBU main company
Sharemaestro market context Price below Trend Line 52 weeks -14.6% · Next-week setup negative 44.9% CRBU stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Akari Therapeutics Q2 Results: Net loss widens to $4.8 million

Akari Therapeutics reported a net loss of $4.8 million for Q2 2026, widening from $1.9 million year-over-year, primarily due to increased R&D expenses as it advances its lead ADC candidate, AKTX-101, towards mid-2027 Phase 1 trials. The company strengthened its financial position by raising …

AKTX main company
Sharemaestro market context Price below Trend Line 52 weeks -79.5% · Next-week setup negative 37.7% AKTX stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Navios Maritime Partners (NMM) Q2 2024 Earnings Report - Results, Call & Slides

This article provides the Q2 2024 earnings report for Navios Maritime Partners (NMM), detailing their actual EPS of $3.06 which beat the consensus of $2.84, and actual revenue of $342.16M, exceeding the expected $312.39M. It includes earnings announcement details, a link to the earnings …

NMM main company
Sharemaestro market context Trend signal active 52 weeks +75.4% · Next-week setup positive 58.9% NMM stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Pharvaris President Lu Peng Reports Two RSU Tax Withholding Share Dispositions

Pharvaris N.V. President Lu Peng reported two share dispositions on August 11 and 12, 2026, totaling 226 shares. These transactions were related to shares withheld by the company to cover tax obligations arising from RSU vesting. Following these dispositions, Lu Peng's direct beneficial ownership …

PHVS main company
Sharemaestro market context Trend signal active 52 weeks +52.0% PHVS stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Martin Marietta Materials, Inc. Raises Quarterly Dividend, Payable on September 30, 2026

Martin Marietta Materials, Inc. announced that its Board of Directors approved an increase in its quarterly cash dividend from $0.83 to $0.84 per share. This translates to an annualized dividend of $3.36 per share. The dividend is payable on September 30, 2026, to shareholders …

MLM main company
Sharemaestro market context Price below Trend Line 52 weeks -9.4% MLM stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Arista Networks (ANET) Q1 2026 Earnings Call Transcript

Image source: The Motley Fool. DATE Tuesday, Aug. 4, 2026 at 4:30 p.m. ET CALL PARTICIPANTS Head of Investor Advocacy - Rudolph Araujo Chairperson and Chief Executive Officer - Jayshree Ullal Chief Financial Officer - Chantelle Breithaupt President and Chief Technology Officer - Kenneth …

ANET main company
Sharemaestro market context Trend signal active 52 weeks +49.2% · Next-week setup positive 58.8% ANET stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Caribou Biosciences, Inc. (CRBU) Reports Q2 Loss, Lags Revenue Estimates

Caribou Biosciences, Inc. (CRBU) reported a Q2 loss of $0.24 per share, outperforming the Zacks Consensus Estimate of a $0.33 loss. However, the company missed revenue estimates, posting $1.5 million against an expected $2.5 million. The stock currently holds a Zacks Rank #3 (Hold), …

CRBU main company
Sharemaestro market context Price below Trend Line 52 weeks -14.6% · Next-week setup negative 44.9% CRBU stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Macquarie, Westpac to testify in KPMG Australia audit scandal probe

SYDNEY, Aug 14 (Reuters) - Leaders from some of Australia's biggest companies, including major banks Macquarie Group and Westpac, will face questioning from lawmakers on Friday as part of ‌a probe into accounting firm KPMG's alleged misuse of client data to win audit ‌contracts. …

MQG main company
Sharemaestro market context Trend signal active 52 weeks +20.8% · Next-week setup positive 57.2% MQG stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Caribou Biosciences Reports Second Quarter 2026 Financial Results and Provides Business Update

Caribou Biosciences has released its financial results for the second quarter of 2026, alongside a business update. The report details the company's financial performance and highlights recent developments in its operations and strategic initiatives.

CRBU main company
Sharemaestro market context Price below Trend Line 52 weeks -14.6% · Next-week setup negative 44.9% CRBU stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Caribou Biosciences reports Q2 2026 results: $1.5M licensing revenue, $24.3M GAAP net loss

Caribou Biosciences reported its Q2 2026 financial results, showing $1.5 million in licensing revenue and a GAAP net loss of $24.3 million. The company holds $113.8 million in cash and expects these funds to support operations through the end of 2027. Business highlights include …

CRBU main company
Sharemaestro market context Price below Trend Line 52 weeks -14.6% · Next-week setup negative 44.9% CRBU stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Caribou Biosciences Q2 Results: Net loss narrows to $24.3 million

Caribou Biosciences reported a narrowed net loss of $24.3 million in Q2 2026, significantly improving from $54.1 million in Q2 2025, beating EPS estimates. This was primarily due to a sharp decline in operating expenses and cost-cutting measures. However, quarterly sales missed analyst forecasts, …

CRBU main company
Sharemaestro market context Price below Trend Line 52 weeks -14.6% · Next-week setup negative 44.9% CRBU stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Find financial news

Search the Newsreel

Use one field or combine several. Results are newest first.

Evidence context